goal_code,goal_labelEN,goal_descEN,target_code,target_descEN,indicator_code,indicator_reference,indicator_tier,indicator_custodians,indicator_descEN,series_release,series_tags,series,seriesDescription,geoAreaCode,geoAreaName,level,parentCode,parentName,type,X,Y,ISO3,UN_Member,Country_Profile,years,min_year,max_year,n_years,unitsCode,unitsDesc,reportingTypeCode,reportingTypeDesc,value_2010,value_2011,value_2012,value_2013,value_2014,value_2015,value_2016,value_2017,latest_value,basePeriod,valueDetails,footnotes,sources,timeDetails,nature
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",104,Myanmar,4,35,South-Eastern Asia,Country,96.51752295,21.19332882,MMR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,60.7301028156894,37.5770163449217,92.6213104621619,114.328708112571,144.189742620438,93.1215521847403,146.75323038332,117.584432833421,117.584432833421,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",108,Burundi,5,14,Eastern Africa,Country,29.89080992,-3.366387428,BDI,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,47.7328440582586,43.7641109557357,37.8515549488072,51.2597268801854,43.2881234963993,50.5217162409654,103.295435012364,94.8328322112706,94.8328322112706,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",11,Western Africa,4,202,Sub-Saharan Africa,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,909.434523523959,831.164700790245,1027.4469047668,1225.35078251676,1424.70198808924,1911.1385885482,1580.45614020602,1660.13484207892,1660.13484207892,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",112,Belarus,4,151,Eastern Europe,Country,28.04940161,53.54193075,BLR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,9.72717524112254,5.12149096573928,6.14423084287643,5.40902894065138,5.48672143824964,1.26387840438819,5.84111461110153,2.91883590770612,2.91883590770612,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",116,Cambodia,4,35,South-Eastern Asia,Country,104.922836,12.71163737,KHM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,100.059501069621,51.7135211147697,53.8147628606967,63.3610919787362,61.7939363603872,65.0893130711953,46.742372918585,76.2840685034383,76.2840685034383,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",12,Algeria,4,15,Northern Africa,Country,2.678164227,28.15940032,DZA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,1.50069194121318,2.7131020465887,0.461593530520231,0.274649465901485,0.146015557534519,0.305486477546541,0.732257277532125,0.422039297472664,0.422039297472664,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",120,Cameroon,5,17,Middle Africa,Country,12.7419827,5.692387031,CMR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,23.5148369068626,91.266424995994,40.0671574815227,67.6155770153295,66.3732812687635,95.6284276799571,52.2025006871257,50.2311793131058,50.2311793131058,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",127,Southern Asia (excluding India),1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,742.438701716508,483.796052792236,637.641173733609,829.307551596425,657.926322760086,675.308107220896,806.592551473717,911.473171909442,911.473171909442,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",13,Central America,4,419,Latin America and the Caribbean,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,77.8820355529797,73.7922932750149,82.9400300151693,68.9791618327731,78.9139634731208,110.693940639732,78.3429351362313,77.7473597041945,77.7473597041945,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",132,Cabo Verde,5,11,Western Africa,Country,-23.63544151,15.07791834,CPV,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,1.08469813197681,2.76990234096372,4.92386385755622,3.19637884489446,1.36525451489961,2.15877047138809,0.487383714180187,1.59684510659503,1.59684510659503,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",135,Caucasus and Central Asia,1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,130.58043536853,120.262068465616,112.839886038966,103.968911219955,115.674420039426,88.1363915567013,141.793225994944,132.878929670649,132.878929670649,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",14,Eastern Africa,4,202,Sub-Saharan Africa,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,1277.38102830618,1477.2897291489,1846.43510626259,2281.1016752349,1931.43163579675,2208.53502471367,2210.94357977891,2539.43448354712,2539.43448354712,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",140,Central African Republic,5,17,Middle Africa,Country,20.93559492,7.003720791,CAF,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,9.38418568479964,9.18921850233825,15.4118021388042,19.3855254615543,36.431968555807,23.2609374645995,49.9120464984373,47.6027308854901,47.6027308854901,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",142,Asia,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,1964.57424207639,1473.70386820135,1807.01867757888,2098.55860971077,1776.68186204417,1889.62713102834,2194.06429611303,2861.18616342293,2861.18616342293,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",143,Central Asia,3,142,Asia,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,89.6816446369492,82.6010188824701,93.815017855652,76.6088551001732,96.4040519605506,74.4542912333603,114.973103600326,113.528541871925,113.528541871925,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",144,Sri Lanka,4,34,Southern Asia,Country,80.70489654,7.614693343,LKA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,27.6436322566831,12.6589198986019,18.1426519292117,15.5054733710208,19.1954932002287,29.4029822452157,16.4584230464014,46.1435071863991,46.1435071863991,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",145,Western Asia,3,142,Asia,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,267.014191897262,204.934439607652,207.330131563893,229.74668765114,278.182225237954,270.098326439465,303.382599786056,735.257543719248,735.257543719248,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",148,Chad,5,17,Middle Africa,Country,18.66618401,15.36279341,TCD,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,39.6784170348625,19.3277391259899,24.6071296343459,58.5889701384798,41.7926384786207,20.6619551531737,60.7510782324489,33.485042416059,33.485042416059,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",15,Northern Africa,3,2,Africa,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,161.957571116736,120.930044903853,129.506886803189,134.71101774955,99.5230142288734,126.971258122316,219.332572665438,114.213813611164,114.213813611164,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",150,Europe,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,46.8421857866969,62.5177420057022,61.3705725823011,59.266539633464,56.2184288104344,70.6611507025613,122.827709929636,106.564152886446,106.564152886446,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",151,Eastern Europe,3,150,Europe,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,31.2618234278123,47.8631215976185,51.1346637977594,49.6613118211935,42.8048308837649,64.0781280928073,85.742523344816,48.6601598206588,48.6601598206588,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",152,Chile,5,5,South America,Country,-71.23029019,-35.2652885,CHL,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,1.06294821174933,0.748555278473522,0.70649927906728,0.368395488199551,0.420122116996266,0.350720959023516,0.202261661085959,0.353321393541339,0.353321393541339,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",156,China,4,30,Eastern Asia,Country,104.1403375,32.30955217,CHN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,106.363745582179,9.88399444440611,94.7030592850665,65.5393206134105,45.4551358376883,53.1364906206878,124.519391687525,99.5933847120583,99.5933847120583,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",17,Middle Africa,4,202,Sub-Saharan Africa,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,427.62351707936,492.123899953196,518.56628711094,627.197113457544,622.153865394697,720.99215969664,646.388036939051,638.741275457381,638.741275457381,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",170,Colombia,5,5,South America,Country,-73.07446751,3.888209046,COL,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,15.0944147152064,12.5488748163779,5.55175451566172,9.14098570378114,8.48099687929256,1.60172066584869,1.5802013723414,9.7785562353176,9.7785562353176,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",174,Comoros,5,14,Eastern Africa,Country,43.34234565,-11.66121732,COM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,7.90741458819329,4.23644943876448,9.62116737203727,6.98412633898078,4.16224572990226,2.29323093586288,6.63297932414893,2.35860106422861,2.35860106422861,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",175,Mayotte,5,14,Eastern Africa,Country,45.14015057,-12.82217691,MYT,0,1,[2010],2010,2010,1,CON_USD,Constant USD,G,Global,1.40589913985905,,,,,,,,1.40589913985905,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",178,Congo,5,11,Western Africa,Country,15.22052612,-0.840544119,COG,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,22.1561307370775,16.6244791867006,26.0226743111678,17.2319775449789,5.67924801408488,9.2451922683127,8.65461057713849,7.50503166656203,7.50503166656203,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",18,Southern Africa,4,202,Sub-Saharan Africa,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,46.8379194865148,121.580894156204,91.0139479143144,165.830217204992,48.9379061274815,103.893982311999,133.536753511908,196.375107368504,196.375107368504,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",180,Democratic Republic of the Congo,5,17,Middle Africa,Country,23.65496507,-2.877154732,COD,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,265.594475177559,304.363756091659,341.882592368799,388.719934536002,418.295266409118,513.933796645972,419.777327437107,427.604371448998,427.604371448998,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",184,Cook Islands,4,61,Polynesia,Country,-159.7711391,-21.22696458,COK,0,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.0590043825305942,0.0882577947831717,0.0531655880751036,0.123605687588361,0.0517232760124578,0.173554435267485,0.0888531918169982,0.0831293331511993,0.0831293331511993,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",188,Costa Rica,5,13,Central America,Country,-84.19712782,9.970998683,CRI,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.20714784067046,-0.366376830015709,0.399083896055596,-0.721283187314576,0.383366348966795,-0.933864714334531,-1.24188614441158,-0.980523378126107,-0.980523378126107,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",191,Croatia,4,39,Southern Europe,Country,17.95874553,45.45172212,HRV,1,1,[2010],2010,2010,1,CON_USD,Constant USD,G,Global,0.0790051953258866,,,,,,,,0.0790051953258866,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",192,Cuba,5,29,Caribbean,Country,-79.54460144,22.10030366,CUB,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,4.48288374550355,3.4727964864358,1.92911314042795,1.7284367455775,2.98615461284579,2.04196484868642,1.3317286937612,0.723969060621089,0.723969060621089,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",199,Least Developed Countries (LDC),1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,2693.71875688558,2767.55449756834,3277.94148088577,4232.1371725473,3997.38579107097,4473.69019736362,4476.05620746176,4739.97002621959,4739.97002621959,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",2,Africa,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,2823.23455951274,3043.0892689524,3612.96913285783,4434.19080616376,4126.74840963703,5071.53101339283,4790.65708310133,5148.89952206309,5148.89952206309,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",202,Sub-Saharan Africa,3,2,Africa,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,2661.27698839601,2922.15922404855,3483.46224605464,4299.4797884142,4027.22539540816,4944.55975527051,4571.3245104359,5034.68570845192,5034.68570845192,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",204,Benin,5,11,Western Africa,Country,2.339933594,9.65401646,BEN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,51.6375574117363,54.002878876804,49.0193768582578,60.4726201212446,63.3875876023964,47.6047683184905,48.4889366511453,87.6463691595891,87.6463691595891,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",212,Dominica,5,29,Caribbean,Country,-61.3493756,15.43391378,DMA,1,1,"[2010, 2011, 2013, 2015, 2017]",2010,2017,5,CON_USD,Constant USD,G,Global,0.00970840433906465,0.0589209782611666,,0.0880142233897404,,0.0920904299037821,,0.0360371891417551,0.0360371891417551,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",214,Dominican Republic,5,29,Caribbean,Country,-70.49847576,18.89832088,DOM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,9.48635964807869,6.30168777474812,8.78252077382539,4.74732217995252,5.41716763140241,2.43556852289354,1.24218930803096,3.01284591110013,3.01284591110013,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",218,Ecuador,5,5,South America,Country,-78.37005241,-1.447785891,ECU,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,10.413142148979,9.26235799235682,4.98346637825656,4.90313143018785,6.53533747670969,2.68013017311015,8.11030959697562,6.7520048920587,6.7520048920587,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",222,El Salvador,5,13,Central America,Country,-88.86862995,13.73603564,SLV,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,7.55324895983109,5.04569283861249,4.62207692251612,3.13264249924758,2.45747579144342,3.11081175142582,4.8161408939576,6.27282652253877,6.27282652253877,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",223,Eastern Asia (excluding Japan and China),3,142,Asia,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,36.7872117379674,33.1909922862638,28.5485412201596,32.843727577473,32.0819790871294,28.0421990564571,43.2016764503682,35.2526160596898,35.2526160596898,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",226,Equatorial Guinea,5,17,Middle Africa,Country,10.46535826,1.565792376,GNQ,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,6.86347152676807,6.93627385204652,1.56007995151893,0.383311947105113,0.404534020644133,0.73427364938735,1.49219989781423,2.30849360684477,2.30849360684477,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",231,Ethiopia,5,14,Eastern Africa,Country,39.63505296,8.631223181,ETH,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,192.219257634314,305.238323477604,322.800233358585,567.15481983104,405.683133064201,387.345281412262,366.148688040576,377.901940068928,377.901940068928,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",232,Eritrea,5,14,Eastern Africa,Country,38.11074289,16.12894644,ERI,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,27.5180482705973,9.36021993642185,11.1036343770571,18.6145294059591,14.4686924579213,12.0326850479121,12.2718131462276,27.2988566681194,27.2988566681194,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",24,Angola,5,17,Middle Africa,Country,17.57817062,-12.33724746,AGO,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,55.0366187514073,37.2511234362303,64.8909167104573,67.2341611080278,46.4006978787983,50.72868491271,44.0567081633533,61.2673180431782,61.2673180431782,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",242,Fiji,4,54,Melanesia,Country,177.9660884,-17.83301566,FJI,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,3.77273968797851,3.20792768507221,9.83065667537935,9.65271388585377,9.72414359359684,14.7785102437967,6.53016638368245,5.34289821521925,5.34289821521925,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",262,Djibouti,5,14,Eastern Africa,Country,42.18274707,11.56004161,DJI,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,3.65502339349522,2.85260452570496,7.52976858364882,3.9958802806914,3.68368346696065,6.35530823705595,10.9891983360292,8.18165089487559,8.18165089487559,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",266,Gabon,5,17,Middle Africa,Country,11.78727747,-0.60687619,GAB,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,2.13977033606314,2.00716282319009,1.37421490067597,2.55647725866207,1.94187008350239,3.09968166245371,4.5006169939947,2.56726606446961,2.56726606446961,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",268,Georgia,4,145,Western Asia,Country,43.3713615,42.04813028,GEO,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,17.9557954279496,14.3558984312144,6.18845267850234,8.32987319255544,6.024519265891,2.96406070004002,8.39735380386869,7.26054263776819,7.26054263776819,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",270,Gambia,5,11,Western Africa,Country,-15.39944785,13.45295927,GMB,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,15.4991874603087,18.308742271084,21.482172616711,23.795439265104,18.053795112685,19.8427425373602,25.7087758321964,49.7672431078546,49.7672431078546,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",275,State of Palestine,4,145,Western Asia,Country,35.25694122,31.94347933,PSE,0,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,74.3231505640886,67.9243384984596,74.2782661290714,49.1379944388163,73.7752518593386,97.6132622196478,78.7978648696895,159.719674667918,159.719674667918,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",28,Antigua and Barbuda,5,29,Caribbean,Country,-61.7999755,17.07761471,ATG,1,1,"[2015, 2017]",2015,2017,2,CON_USD,Constant USD,G,Global,,,,,,0.00389500063122498,,0.042017001816797,0.042017001816797,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",288,Ghana,5,11,Western Africa,Country,-1.205623522,7.964825185,GHA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,124.473288636776,96.0608669129572,166.673692800543,144.396933332145,121.534693823309,142.233177291607,138.105681050507,123.659384372321,123.659384372321,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",29,Caribbean,4,419,Latin America and the Caribbean,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,30.1047614495049,84.328240673598,65.9085714870057,69.3306559253031,52.2363553353192,63.1917704961889,103.768571477613,101.045247043043,101.045247043043,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",296,Kiribati,4,57,Micronesia,Country,-157.5643005,1.768837732,KIR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.24136549059972,0.253089560976011,1.75043182709706,1.06213295396128,0.809533399358255,1.11721855448276,1.08846698412387,2.59448992015221,2.59448992015221,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",30,Eastern Asia,3,142,Asia,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,143.150957320146,43.0749867306703,123.251600505226,98.3830481908832,77.5371149248181,81.1786896771448,167.721068137894,134.846000771748,134.846000771748,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",308,Grenada,5,29,Caribbean,Country,-61.68248568,12.11238395,GRD,1,1,"[2011, 2012, 2013, 2014, 2015, 2016, 2017]",2011,2017,7,CON_USD,Constant USD,G,Global,,0.0,-0.00800841401368282,0.0086584930657287,-0.0157763947538927,0.0019599969824463,-0.0108574232271809,-0.560391791177875,-0.560391791177875,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",31,Azerbaijan,4,145,Western Asia,Country,50.01064725,40.39229544,AZE,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,8.72258028122244,12.9301847058988,4.0908319683711,9.71259140201457,7.67349828827879,5.3239200961139,3.59042653102105,8.19481771290582,8.19481771290582,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",32,Argentina,5,5,South America,Country,-65.14563274,-35.19446255,ARG,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,17.0707319096022,5.82827052966447,0.794421434542235,-4.13114888931372,0.658928200140948,-55.3150256413724,-10.3740447242967,-9.41774753917181,-9.41774753917181,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",320,Guatemala,5,13,Central America,Country,-91.2312746,15.00273719,GTM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,15.6239046940911,28.3562049184383,20.7073294776572,24.6617734492701,25.8561659329725,47.6259423967272,21.3317659761462,25.2468324883926,25.2468324883926,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",324,Guinea,5,11,Western Africa,Country,-11.28173419,11.00210343,GIN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,24.1710767023725,6.91851483408676,29.4651177834605,16.285428739136,95.92904531948,141.948227915268,103.985059133825,78.7982612713095,78.7982612713095,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",328,Guyana,5,5,South America,Country,-58.97322037,4.788012784,GUY,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,4.76069212490986,2.33817473680013,2.72012611677598,0.770596821071281,0.99754949164608,1.66103136230698,1.99608534978463,3.38394360992936,3.38394360992936,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",332,Haiti,5,29,Caribbean,Country,-72.33640958,18.40426539,HTI,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,14.8202700321493,73.5921112687045,54.210688755976,62.1907701833452,42.3326316403184,58.0360248158254,99.9213630413667,94.5901151449857,94.5901151449857,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",34,Southern Asia,3,142,Asia,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,986.440457117548,753.042277952476,853.179797790373,1159.63351883037,846.29520107107,991.088404542918,1101.28874627365,1107.20656961983,1107.20656961983,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",340,Honduras,5,13,Central America,Country,-86.59974381,14.82243161,HND,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,27.9829874242764,23.3105879358843,30.5359507384502,15.6591532313181,26.7606576457993,36.5894054616953,27.1479407104627,8.7156883386431,8.7156883386431,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",35,South-Eastern Asia,3,142,Asia,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,478.286991104481,390.051145028072,529.44212986374,534.186499938197,478.26326884978,472.807419135446,506.698778315112,770.34750744017,770.34750744017,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",356,India,4,34,Southern Asia,Country,79.3608464,22.34642074,IND,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,244.001755401043,269.246225160241,215.538624056764,330.325967233949,188.368878310985,315.780297322022,294.696194799929,195.733397710395,195.733397710395,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",360,Indonesia,4,35,South-Eastern Asia,Country,113.9174,-0.994582204,IDN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,102.409633680324,95.0498261617696,168.085218046932,135.280392215472,60.9151129353059,79.6275745045524,111.711863469237,342.991311616722,342.991311616722,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",364,Iran (Islamic Republic of),4,34,Southern Asia,Country,54.19766348,32.74370885,IRN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,5.06158314028159,4.67565030144446,10.2225468484681,4.956546770414,4.0859454152792,3.5271054253546,2.46900804559675,1.6450105,1.6450105,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",368,Iraq,4,145,Western Asia,Country,43.76606267,33.05013795,IRQ,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,50.6771915166041,14.938563492147,5.10653954300985,23.3033462156238,11.8414832653315,11.8589545032865,4.91137453546429,6.31876034527761,6.31876034527761,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",384,Côte d'Ivoire,5,11,Western Africa,Country,-5.552690016,7.62211586,CIV,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,70.5446820094519,27.4941878901647,35.020087907689,56.8284001597938,73.6211682266654,52.2701754383744,101.979357479513,93.3345459352812,93.3345459352812,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",388,Jamaica,5,29,Caribbean,Country,-77.31068409,18.15616857,JAM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,1.25523601711192,0.557718771937782,0.470946326416963,0.140408293321467,0.0721728218697139,0.181623623141371,0.104617285236871,2.66582442815833,2.66582442815833,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",39,Southern Europe,3,150,Europe,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,15.5803623588846,14.6546204080837,10.2359087845417,9.60522781227056,13.4135979266695,6.5830226097539,37.08518658482,57.9039930657864,57.9039930657864,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",398,Kazakhstan,4,143,Central Asia,Country,66.65359159,48.01963494,KAZ,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,27.2972833438765,17.4460469456362,12.8509875622023,7.14359227740983,8.76957189763574,4.33600006905204,6.5780198765709,11.0079135486106,11.0079135486106,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",4,Afghanistan,4,34,Southern Asia,Country,66.02688198,33.83160199,AFG,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,128.013504510892,138.467677713928,145.08947372529,222.475573524846,241.363397114545,170.529884593694,204.944171780014,202.36996846328,202.36996846328,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",400,Jordan,4,145,Western Asia,Country,37.13024774,30.65365973,JOR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,36.3638717213626,20.5199413577888,29.5830350714611,18.3650366022331,24.5161789948182,37.7088547898282,24.9744892131718,33.6365603309423,33.6365603309423,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",404,Kenya,5,14,Eastern Africa,Country,37.86096816,0.534797278,KEN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,179.391074333267,187.281680859622,179.506868054608,188.402257546199,193.86928582238,190.178629490173,160.935040631416,240.791012924683,240.791012924683,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",408,Democratic People's Republic of Korea,4,30,Eastern Asia,Country,127.1803633,40.1462645,PRK,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,27.9949410230815,15.8915595236599,16.8202995106761,22.9166931823939,25.7147585213029,23.9144557415518,23.3285444756555,24.1890712041632,24.1890712041632,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",417,Kyrgyzstan,4,143,Central Asia,Country,74.52324839,41.46204516,KGZ,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,10.4218801371591,18.9931976954239,18.9284584762139,15.6943305328875,23.9797136473763,21.3215264017551,17.1336718371597,24.1380371716804,24.1380371716804,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",418,Lao People's Democratic Republic,4,35,South-Eastern Asia,Country,101.9901968,20.27482773,LAO,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,24.2975599736806,26.935586100029,34.2892712128264,39.0329224046211,34.9001285717952,31.662281473586,21.510744709413,31.2829660299729,31.2829660299729,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",419,Latin America and the Caribbean,3,19,Americas,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,236.387643453015,265.626629077267,240.737705742508,214.148863477218,179.030707617534,162.410011431603,226.640653836034,237.332835243649,237.332835243649,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",422,Lebanon,4,145,Western Asia,Country,35.89391711,33.92152458,LBN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,20.5370995357238,18.1559724887999,20.3474194150898,23.3131233280252,41.1507101917419,29.3441845134028,35.1697946144737,38.3235804757898,38.3235804757898,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",426,Lesotho,5,18,Southern Africa,Country,28.25362195,-29.58041814,LSO,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,17.3146703236033,33.3778782532432,28.2640532445093,68.2220129050237,2.42262825164592,2.15826207640578,14.1087808754444,30.8862804528851,30.8862804528851,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",430,Liberia,5,11,Western Africa,Country,-9.311879038,6.448381009,LBR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,47.3759814006039,53.0562145059714,67.3047469361091,58.3197221035606,117.132842571165,214.231619101067,68.3469309396448,64.3041933990041,64.3041933990041,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",432,Landlocked developing countries (LLDCs),1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,1336.46539499439,1547.13860183338,1816.97232143235,2262.16515569157,1915.57621073225,2068.7172673005,2383.8408038526,2512.97398768058,2512.97398768058,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",434,Libya,4,15,Northern Africa,Country,18.0295985,27.04042819,LBY,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.564963032217649,2.75477119043729,0.500093213133896,3.39637605975742,0.0908478199994216,0.0112781705139454,0.46836411491819,5.68142997606331,5.68142997606331,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",450,Madagascar,5,14,Eastern Africa,Country,46.6982339,-19.38514785,MDG,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,106.348697074877,59.1601873891766,57.8296621963596,102.644615938438,81.6642609156284,111.979090841157,102.58641626324,81.1004633719263,81.1004633719263,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",454,Malawi,5,14,Eastern Africa,Country,33.4884625,-13.40819859,MWI,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,59.4890678829675,147.700829843511,151.306855263969,160.550476500847,89.9551724486772,161.697949990223,230.759839555924,288.524259519337,288.524259519337,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",458,Malaysia,4,35,South-Eastern Asia,Country,116.8346314,5.452415309,MYS,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,-3.93874149723738,-3.72479951383523,-3.69380052490984,-3.71545832267781,-3.62999015645146,-3.34197105976844,-2.46804039984332,-1.3966165036448,-1.3966165036448,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",462,Maldives,4,34,Southern Asia,Country,73.09672546,-0.614385021,MDV,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.255075546592989,0.695215081679135,0.441252635582142,0.350451961846548,0.534407813447176,1.05543657831813,0.543530068061233,0.60289525,0.60289525,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",466,Mali,5,11,Western Africa,Country,-3.522016039,17.35311254,MLI,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,100.448363273736,109.555236347652,98.054595520849,107.720322894708,83.8697399479886,133.804264284308,136.202557007668,129.836005585145,129.836005585145,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",478,Mauritania,5,11,Western Africa,Country,-10.33187259,20.26089546,MRT,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,7.49890964858357,5.62494702297483,1.94844241603196,10.4719052764772,13.2851537747141,13.1641095387593,9.53395043989487,16.0242311478109,16.0242311478109,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",480,Mauritius,5,14,Eastern Africa,Country,57.568022,-20.28581998,MUS,1,1,"[2011, 2012, 2013, 2014, 2015, 2016, 2017]",2011,2017,7,CON_USD,Constant USD,G,Global,,0.21417853396725,0.074397162258172,0.323629533221491,0.0841087708259268,0.179323383324115,0.360935968199738,1.09474621087814,1.09474621087814,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",484,Mexico,5,13,Central America,Country,-102.5148166,23.93378032,MEX,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,3.51433476638838,3.1795353821699,3.86614049760657,2.46591915277353,1.34214292386391,0.607690742724055,1.41648325450524,4.01647098777881,4.01647098777881,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",496,Mongolia,4,30,Eastern Asia,Country,103.0728057,46.83892054,MNG,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,8.79227071488589,17.2994327626038,11.7282417094835,9.92703439507908,6.36722056582645,4.12774331490526,19.8731319747127,11.0635448555267,11.0635448555267,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",498,Republic of Moldova,4,151,Eastern Europe,Country,28.4650624,47.20236795,MDA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,16.9247150865356,24.3957396544439,24.9843815044305,23.4635487151529,11.664156060142,10.8839321628348,13.7696393964674,11.7357759877116,11.7357759877116,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",499,Montenegro,4,39,Southern Europe,Country,19.25214024,42.78717043,MNE,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.72362264884684,0.166457725961479,0.26791634862343,0.200075009846269,-0.025419146123114,-0.365559279949731,0.73470106185049,-0.39923764,-0.39923764,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",5,South America,4,419,Latin America and the Caribbean,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,128.40084645053,107.506095128653,91.8891042403326,75.8390457191411,47.8803888090943,-11.4756997043171,44.529147222189,58.5402284964109,58.5402284964109,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",50,Bangladesh,4,34,Southern Asia,Country,89.17660788,22.86961622,BGD,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,176.753673577096,147.461823925546,122.783241405342,250.412489670137,138.345662836547,213.327174467805,198.76958173517,218.192434648329,218.192434648329,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",500,Montserrat,5,29,Caribbean,Country,-62.19261223,16.73558313,MSR,0,1,"[2010, 2011, 2013, 2014]",2010,2014,4,CON_USD,Constant USD,G,Global,-0.0116320410489592,0.157806576652395,,0.195643359774408,0.781954771120775,,,,0.781954771120775,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",504,Morocco,4,15,Northern Africa,Country,-6.281942841,31.8440131,MAR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,22.4280051601509,18.8226804771774,3.44118857409617,9.44291514768713,7.87741983211449,2.65139888496115,66.7787351324074,18.2441347671959,18.2441347671959,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",508,Mozambique,5,14,Eastern Africa,Country,38.18479941,-14.27963886,MOZ,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,115.585535298439,120.030111617403,154.875588427911,201.407944801759,244.045845248302,243.456984501507,236.900859582431,229.533442541381,229.533442541381,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",51,Armenia,4,145,Western Asia,Country,44.93839317,40.29499741,ARM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,14.2204150224089,10.3749664460329,8.74558353644059,9.3175915252122,5.57235052470532,5.39411952718717,14.832342059728,3.89502744804983,3.89502744804983,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",514,Developed Regions,1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,46.8421857866969,62.5177420057022,61.3705725823011,59.266539633464,56.2184288104344,70.6611507025613,122.827709929636,106.564152886446,106.564152886446,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",515,Developing Regions,1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,6634.51936012341,6253.19699369492,7084.2642832235,8546.0475530517,7767.93796213578,9127.99397281809,9174.02529823176,10687.7991538885,10687.7991538885,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",516,Namibia,5,18,Southern Africa,Country,17.21907885,-22.13817068,NAM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,4.64031412920827,5.05571680986385,5.29247224161569,7.89850209082258,8.99370103188043,3.7098264886303,10.0046627570096,13.5992918382719,13.5992918382719,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",52,Barbados,5,29,Caribbean,Country,-59.5346489,13.13648273,BRB,1,1,[2010],2010,2010,1,CON_USD,Constant USD,G,Global,0.00970840433906465,,,,,,,,0.00970840433906465,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",520,Nauru,4,57,Micronesia,Country,166.92313,-0.528742623,NRU,1,1,"[2011, 2012, 2013, 2014, 2015, 2016, 2017]",2011,2017,7,CON_USD,Constant USD,G,Global,,0.0150458779947578,0.195020943935177,0.222380986131967,0.086048552711212,8.04956999158703,0.523179779723911,0.449543224379646,0.449543224379646,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",524,Nepal,4,34,Southern Asia,Country,83.94678863,28.25866332,NPL,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,76.9325095240857,55.1120625839904,54.3543187289579,75.6970257491319,105.176308127402,99.4665203558352,71.188301532573,60.0930993245414,60.0930993245414,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",54,Melanesia,3,9,Oceania,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,41.3269218117163,57.3852887255365,59.019745178741,78.6292785424825,42.9764635991077,101.58268280062,45.1104492825151,58.2811199774468,58.2811199774468,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",548,Vanuatu,4,54,Melanesia,Country,167.0679779,-15.34445547,VUT,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,3.93581338466334,6.41386829545233,5.30507277787911,8.30045627458215,5.23830942236215,5.79987362706312,1.98251140647372,4.0944281962027,4.0944281962027,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",558,Nicaragua,5,13,Central America,Country,-85.03060315,12.84210839,NIC,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,23.7468478041248,15.3712509839574,23.2703363324536,24.4813582173357,21.3822671459322,19.2781802426703,21.9253462037589,30.026191173113,30.026191173113,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",562,Niger,5,11,Western Africa,Country,9.400167877,17.42143036,NER,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,63.8136841290998,45.3140543089988,30.9986135553385,54.3373190178841,83.1585417449257,67.8967860555544,73.1386662378039,84.7753730687945,84.7753730687945,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",566,Nigeria,5,11,Western Africa,Country,8.097363256,9.585789025,NGA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,180.034006067601,247.92713924609,320.611105809338,472.439941000301,436.113167082783,706.500588667183,477.493234695272,654.71237955566,654.71237955566,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",57,Micronesia,3,9,Oceania,Region,,,,,,"[2010, 2011, 2013, 2014, 2015, 2016, 2017]",2010,2017,7,CON_USD,Constant USD,G,Global,0.64116777836941,0.761041892116583,,2.39266114893555,1.48399321029647,9.59101988146541,1.91817056645721,3.8341698595614,3.8341698595614,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",570,Niue,4,61,Polynesia,Country,-169.8601693,-19.05000475,NIU,0,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.210132415226976,0.0309569595076346,0.0133068921505308,0.160054582501937,0.0132436191160898,0.0277314035816612,0.00992429688438951,0.0487045731511993,0.0487045731511993,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",583,Micronesia (Federated States of),4,57,Micronesia,Country,158.225216,6.880670092,FSM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.233372445833193,0.188078588210778,0.182791169140376,0.561074065517494,0.402473351783564,0.380069636613828,0.342862653269926,0.507126999381314,0.507126999381314,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",584,Marshall Islands,4,57,Micronesia,Country,171.0839119,7.110213497,MHL,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,-0.086860257492741,0.256677681705656,0.203535588862438,0.33486119488649,0.161139061284559,-0.115191801543773,-0.093369823170616,0.200194451904274,0.200194451904274,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",585,Palau,4,57,Micronesia,Country,134.5733878,7.502307591,PLW,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.253290099429237,0.048150183229379,0.0452513292070031,0.212211948438315,0.0247988451588799,0.159353500325559,0.057030972510127,0.0828152637439535,0.0828152637439535,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",586,Pakistan,4,34,Southern Asia,Country,68.80479684,29.36491634,PAK,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,327.336729131842,123.299083207013,284.5119798311,258.023931503057,146.113984773854,153.91488495867,310.134632681083,379.851501788044,379.851501788044,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",591,Panama,5,13,Central America,Country,-81.26616623,8.450965746,PAN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,-1.55491413572021,-1.65328759415806,-0.953232138957859,-1.3824876970828,-0.47041766627558,1.15984444926275,-0.21613699033753,2.4018075383781,2.4018075383781,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",598,Papua New Guinea,4,54,Melanesia,Country,145.8587761,-6.756057077,PNG,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,24.4610135511517,42.0785291729892,38.8897975913778,36.1117624513237,23.2075036778612,62.9133941109535,20.3000259204045,44.5849758267104,44.5849758267104,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",600,Paraguay,5,5,South America,Country,-60.54854225,-21.70216237,PRY,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,10.448842061596,3.71136251404481,6.50982636066135,3.67592279061758,3.37293467376881,4.8864276401473,5.23156894347524,6.88629308825843,6.88629308825843,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",604,Peru,5,5,South America,Country,-71.82093277,-13.58939705,PER,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,16.3040811045636,20.8971424457693,37.9351982571934,32.4868000403969,9.82146049871896,8.90633455579948,14.6190867780923,11.6838429803001,11.6838429803001,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",608,Philippines,4,35,South-Eastern Asia,Country,120.8601418,14.16591706,PHL,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,65.5445840901778,57.053900965197,31.1049985614593,33.1963772783687,53.6174383671515,95.2976307334859,68.398857538697,72.737660721086,72.737660721086,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",61,Polynesia,3,9,Oceania,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,6.50049903617671,12.5789968494012,6.19990095961375,7.84114700680225,1.75020060996475,7.87087435211185,10.1551772105249,8.87534590839915,8.87534590839915,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",624,Guinea-Bissau,5,11,Western Africa,Country,-14.40182514,12.11760394,GNB,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,19.9546739218586,6.118118036916,14.8197627383646,33.8820409962628,10.9265575631254,18.5387408648932,20.577412635726,21.9095278252611,21.9095278252611,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",626,Timor-Leste,4,35,South-Eastern Asia,Country,125.9451052,-8.797497247,TLS,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,8.08072828149748,3.15267563446272,13.0414630147318,6.96819198528592,11.0258279621594,14.1863365490833,15.8709320516713,12.0095508829734,12.0095508829734,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",64,Bhutan,4,34,Southern Asia,Country,90.45098484,27.39598568,BTN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.441994029034747,1.42562008003306,2.09570862965821,1.88605904597083,3.11112347878124,4.08411859600443,2.08490258481751,2.57475474884826,2.57475474884826,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",646,Rwanda,5,14,Eastern Africa,Country,29.92310194,-1.999842114,RWA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,70.334746683823,73.321107454606,75.7167509715904,83.2887919009508,102.534977589595,84.8994874803475,80.8423204656159,87.2958732270921,87.2958732270921,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",660,Anguilla,5,29,Caribbean,Country,-63.05651612,18.21525315,AIA,0,1,[2013],2013,2013,1,CON_USD,Constant USD,G,Global,,,,0.00129166915164156,,,,,0.00129166915164156,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",662,Saint Lucia,5,29,Caribbean,Country,-60.96529553,13.89405601,LCA,1,1,"[2011, 2012, 2013, 2014, 2015, 2016, 2017]",2011,2017,7,CON_USD,Constant USD,G,Global,,0.187198816858159,0.0414591535117781,0.066450427991879,0.468837826575303,0.188875656827359,1.15176843414293,0.542601053397708,0.542601053397708,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",670,Saint Vincent and the Grenadines,5,29,Caribbean,Country,-61.19024321,13.24627968,VCT,1,1,"[2011, 2012, 2013, 2014, 2015, 2016, 2017]",2011,2017,7,CON_USD,Constant USD,G,Global,,0.0,0.481851750861239,0.163660349733043,0.19321242594062,0.209767601297295,0.0277621383021654,-0.007770955,-0.007770955,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",678,Sao Tome and Principe,5,17,Middle Africa,Country,6.609772265,0.241554875,STP,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,3.25561092396011,5.15772193904665,2.74971961364862,5.48117844740609,4.83436068535795,3.6992102600737,5.04094845163041,6.16984201267381,6.16984201267381,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",68,Bolivia (Plurinational State of),5,5,South America,Country,-64.66224284,-16.71273412,BOL,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,28.7313029201151,30.1864397066612,28.0823880920522,20.1195278066055,16.0338291497484,21.4426582824713,18.5511865123063,21.0596159883142,21.0596159883142,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",686,Senegal,5,11,Western Africa,Country,-14.46636926,14.35920905,SEN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,54.2545389547637,53.0829504311704,82.9573557150437,72.0447471065186,107.809850614747,84.195378352767,83.3236845368262,67.8906617962267,67.8906617962267,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",688,Serbia,4,39,Southern Europe,Country,20.805876,44.03145697,SRB,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,2.53314257915967,1.85171860719018,1.35852499953619,1.67963865743845,1.95799239812318,0.973893708504007,0.811807944102337,25.1626434296789,25.1626434296789,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",690,Seychelles,5,14,Eastern Africa,Country,55.46561591,-4.678053059,SYC,1,1,"[2011, 2012, 2013, 2014, 2015, 2016, 2017]",2011,2017,7,CON_USD,Constant USD,G,Global,,0.0990429360357915,0.18823258033875,0.245046815001557,0.15427568596032,0.154122669129113,3.04831183343237,0.01764944,0.01764944,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",694,Sierra Leone,5,11,Western Africa,Country,-11.78306584,8.568604164,SLE,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,32.436516474587,25.0985685711117,23.5320932739132,29.4073984661056,101.092979176009,143.57928667549,83.3270319731497,64.7445225642132,64.7445225642132,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",70,Bosnia and Herzegovina,4,39,Southern Europe,Country,17.78584332,44.16845548,BIH,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,7.44558951088148,5.79389422256475,6.37305858554483,5.06951686167199,9.93065408239638,4.1600935864482,34.2314279523712,31.9522238239133,31.9522238239133,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",704,Viet Nam,4,35,South-Eastern Asia,Country,105.802499,10.09643079,VNM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,105.452690345534,89.6280531785265,128.390422685552,121.268513601268,85.8682686671945,69.881461861721,72.0997212843521,81.3463644232578,81.3463644232578,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",706,Somalia,5,14,Eastern Africa,Country,46.20367477,4.406485729,SOM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,25.0697188705673,25.9558577179141,51.6900477770243,53.5400698596088,62.2539793693829,55.4375434441615,51.3012515235991,54.1185718939723,54.1185718939723,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",710,South Africa,5,18,Southern Africa,Country,24.67184355,-29.99957544,ZAF,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,16.165928520232,66.6606875771952,49.8554071089993,79.2745649438268,30.5749267266306,88.8700567701313,85.8588921998497,121.047699141935,121.047699141935,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",716,Zimbabwe,5,14,Eastern Africa,Country,29.86909584,-19.00075492,ZWE,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,84.3823022250161,56.839440590295,113.29283946491,83.4575058242234,62.7038291034669,120.455778850274,79.9781856730701,147.702744941143,147.702744941143,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",72,Botswana,5,18,Southern Africa,Country,23.81380223,-22.18810073,BWA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,4.63367229977054,4.00332782114848,2.72722525045221,3.34706544376046,3.9049989029445,3.34171741081619,5.41556596982228,17.1922257916706,17.1922257916706,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",722,Small island developing States (SIDS),1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,130.372366045185,182.202499833205,184.07192827081,218.590309891923,134.409346918997,231.197457227782,216.455462905194,225.363348987576,225.363348987576,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",728,South Sudan,5,14,Eastern Africa,Country,30.32618773,7.290839152,SSD,1,1,"[2011, 2012, 2013, 2014, 2015, 2016, 2017]",2011,2017,7,CON_USD,Constant USD,G,Global,,44.578186277794,98.5060787254772,81.9516211542061,93.0460570354755,117.385022983713,61.0378026555691,172.792101139581,172.792101139581,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",729,Sudan,4,15,Northern Africa,Country,29.95650159,16.02643066,SDN,0,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,117.810228135249,82.8395039593277,112.427262902626,116.153282413077,85.92856075065,111.253677965652,133.738832306755,84.7094000588921,84.7094000588921,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",740,Suriname,5,5,South America,Country,-55.90626394,4.132603197,SUR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,5.43696787695608,1.58085975820397,1.23120108464343,1.2574203371102,0.690059919720031,1.79873360124182,0.540483645485449,2.7757912051391,2.7757912051391,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",748,Eswatini,5,18,Southern Africa,Country,31.50149288,-26.56471011,SWZ,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,4.08333421370086,12.4832836947528,4.87479006873777,7.08807182155865,3.04165121438006,5.81411956601575,18.1488517097825,13.6496101437416,13.6496101437416,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",76,Brazil,5,5,South America,Country,-53.08432878,-10.77668561,BRA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,15.6854559087415,19.6319711137642,2.58126708110292,6.79611815773044,0.87172218659799,1.1026335426332,4.42936939862592,4.71342814909276,4.71342814909276,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",760,Syrian Arab Republic,4,145,Western Asia,Country,38.50466565,35.01676176,SYR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,13.9701233647269,13.7275419582883,8.71342216174368,5.26805531884945,4.93627838655524,11.2507474333198,13.4599866932819,29.017733156352,29.017733156352,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",762,Tajikistan,4,143,Central Asia,Country,69.294998,38.43069666,TJK,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,27.5917483124279,23.8615606845663,27.1786668988,23.2643203691774,30.1331970922579,24.0262602979021,25.3379357150326,37.241403008075,37.241403008075,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",764,Thailand,4,35,South-Eastern Asia,Country,101.0202951,15.13089239,THA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,15.650932345193,32.6653650422307,11.7884835442897,24.4657606845513,29.5828035218003,27.28323981685,26.0790963596794,37.5077689329437,37.5077689329437,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",768,Togo,5,11,Western Africa,Country,0.97835765,8.532096072,TGO,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,20.045495232968,30.6311139696171,6.59347522618669,30.7142343861199,19.511129544021,13.5362560241134,37.400502648786,43.9892029101475,43.9892029101475,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",772,Tokelau,4,61,Polynesia,Country,-171.8154473,-9.214545558,TKL,0,1,"[2011, 2013, 2014, 2015, 2016, 2017]",2011,2017,6,CON_USD,Constant USD,G,Global,,0.0212434994049132,,0.0128215866871048,0.0146193231533582,0.0197572877859073,0.0290726129799016,0.02737256,0.02737256,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",776,Tonga,4,61,Polynesia,Country,-175.1959991,-21.19511329,TON,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,1.98725376855254,10.8207554280102,3.94847228055896,0.678081272777579,0.62483045874195,1.81347176583707,5.12568040609026,3.89616738731471,3.89616738731471,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",780,Trinidad and Tobago,5,29,Caribbean,Country,-61.29389504,10.41877263,TTO,1,1,[2010],2010,2010,1,CON_USD,Constant USD,G,Global,0.0522272390322798,,,,,,,,0.0522272390322798,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",788,Tunisia,4,15,Northern Africa,Country,9.572737411,34.11439971,TUN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,3.62347273531357,2.21348532738176,0.785169584016258,1.0894691682969,1.85930412235156,3.20526216903587,2.24121444656329,4.51964227589721,4.51964227589721,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",792,Turkey,4,145,Western Asia,Country,35.42890329,38.9899684,TUR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.606287442094646,0.642264888794565,2.16400972723464,2.64727223935883,1.70488044980405,1.81838685072588,28.9138566376849,165.64438187371,165.64438187371,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",795,Turkmenistan,4,143,Central Asia,Country,58.9787665,40.0912346,TKM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,5.22653288902782,5.25871417089762,1.62047471490009,5.40857235350611,4.03993346509631,2.46279087033002,9.807995005555,2.71539604,2.71539604,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",798,Tuvalu,4,61,Polynesia,Country,178.6679611,-7.460048071,TUV,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.179423143162899,0.188508244348781,0.0944680612184595,0.174859692369604,0.107112733755239,0.383313321198985,0.677261132269956,0.100938649094905,0.100938649094905,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",8,Albania,4,39,Southern Europe,Country,20.06660928,41.13897007,ALB,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,4.18724020078841,4.31016521346975,2.38648737955759,0.897905519089741,1.08707393924694,0.54361666228718,0.30902464718729,0.42617937809202,0.42617937809202,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",800,Uganda,5,14,Eastern Africa,Country,32.39100438,1.279557331,UGA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,93.0690760155164,99.5203531869672,206.416865451258,145.880990078264,189.692752346567,200.808310153799,259.833172126238,218.569696989096,218.569696989096,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",804,Ukraine,4,151,Eastern Europe,Country,31.40270802,49.00735945,UKR,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,4.60993310015418,18.3458909774353,20.0060514504524,20.7887341653892,25.6539533853733,51.9303175255844,66.1317693372472,34.0055479252411,34.0055479252411,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",807,North Macedonia,4,39,Southern Europe,Country,21.7007909,41.60048068,MKD,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.611762223882338,2.53238463889754,-0.150078528720398,1.75809176422414,0.463296653026073,1.27097793246425,0.998224979308679,0.76218407410225,0.76218407410225,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",818,Egypt,4,15,Northern Africa,Country,29.77468534,26.57438204,EGY,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,16.0302101125906,11.5865019029404,11.891578998796,4.35432549483025,3.62086614622324,9.54415445460612,15.373169387262,0.63716723564329,0.63716723564329,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",834,United Republic of Tanzania,5,14,Eastern Africa,Country,34.80521182,-6.265332606,TZA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,217.37151435489,209.385273427351,249.658994258539,306.180401736602,276.103991332441,317.849453093944,263.658235683041,289.985454067393,289.985454067393,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",84,Belize,5,13,Central America,Country,-88.70199554,17.19965901,BLZ,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.808478199317886,0.548685640126317,0.492344289387833,0.682086167225397,1.20230535041828,3.25593030956056,3.16328123214969,2.04806603347618,2.04806603347618,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",854,Burkina Faso,5,11,Western Africa,Country,-1.742843829,12.27491081,BFA,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,96.1618640675355,49.2012652236835,74.0424017514108,51.0379508065043,77.910481470325,109.633697011574,172.356975229884,77.1460952737094,77.1460952737094,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",858,Uruguay,5,5,South America,Country,-56.01387025,-32.8002838,URY,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,2.50797673924471,0.28647311128155,0.468101913389327,0.091702841244986,-0.278228478242519,-0.691530467465369,-0.43753900550664,-0.376378859588505,-0.376378859588505,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",860,Uzbekistan,4,143,Central Asia,Country,63.11944558,41.77560518,UZB,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,19.1441999544577,17.0414993859461,33.2364302035356,25.0980395671925,29.4816358581843,22.3077135943209,56.1154811660074,38.4257921035588,38.4257921035588,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",862,Venezuela (Bolivarian Republic of),5,5,South America,Country,-66.15642084,7.121324748,VEN,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,0.884290728866724,0.485613125255309,0.324853726986175,0.359593191509433,0.27567669399703,0.100465621938138,0.0801776938195259,0.947557353219518,0.947557353219518,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",876,Wallis and Futuna Islands,4,61,Polynesia,Country,-176.2034788,-13.28471201,WLF,0,1,"[2010, 2011, 2012, 2013, 2016, 2017]",2010,2017,6,CON_USD,Constant USD,G,Global,-0.254676374153954,-0.259151114990836,-0.263149321882313,-0.268240606780537,,,2.73011729340717,0.612619882029597,0.612619882029597,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",882,Samoa,4,61,Polynesia,Country,-172.4430749,-13.61541469,WSM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,4.31936170085765,1.68842603833728,2.35363745949301,6.95996479165819,0.938671199185652,5.45304613844074,1.49426827707624,4.10641352365754,4.10641352365754,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",887,Yemen,4,145,Western Asia,Country,45.22389143,15.22242099,YEM,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,29.6376770210811,31.3647673402281,48.1125713329679,80.3518033884512,100.987074011489,66.8218358059127,90.3351108276718,283.246465070536,283.246465070536,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",894,Zambia,5,14,Eastern Africa,Country,27.850329,-14.59701056,ZMB,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,45.9008084820967,87.7517709800261,118.465567288205,225.219240808727,64.0372219126561,145.505105957861,180.363093957791,217.33458637321,217.33458637321,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",9,Oceania,2,1,World,Region,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,48.4685886262624,70.7253274670542,67.5966769965968,88.8630866982204,46.2106574193689,119.044577034197,57.1837970594972,70.9906357454074,70.9906357454074,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",90,Solomon Islands,4,54,Melanesia,Country,160.1584117,-9.622391719,SLB,1,1,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,9.15735518792273,5.68496357202276,4.99421813410473,24.5643459307229,4.80650690528755,18.0909048188071,16.2977455719544,4.25881773931453,4.25881773931453,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
3,Goal 3,Ensure healthy lives and promote well-being for all at all ages,3.b,"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all",C030b02,3.b.2,I,OECD,Total net official development assistance to medical research and basic health sectors,2019.Q4.G.01,"['means of implementation', 'development finance', 'health', 'medical research']",DC_TOF_HLTHNT,"Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2017 United States dollars)",921,ODA residual,1,,,Group,,,,,,"[2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]",2010,2017,8,CON_USD,Constant USD,G,Global,1515.01214066829,1337.53415799115,1294.57151746539,1651.01964736828,1583.04789660724,1814.72008922856,1782.65175819223,2262.82584452696,2262.82584452696,,,"Net Disbursements | Based on OECD, CRS databased, 2019 | Constant 2017 USD million",OECD,,C: Country data
